Bulletin
Investor Alert

Cyclerion Therapeutics Inc.

NAS: CYCN

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

May 26, 2023, 7:29 p.m.

/zigman2/quotes/207301221/lastsale

$

4.07

Change

-0.0100 -0.25%

Volume

Volume 20

Quotes are delayed by 20 min

/zigman2/quotes/207301221/lastsale

Previous close

$ 4.07

$ 4.08

Change

+0.0100 +0.25%

Day low

Day high

$4.08

$4.22

Open

52 week low

52 week high

$3.64

$25.00

Open

Cheryl Gault

Cheryl Gault is Chief Operating Officer for Cyclerion Therapeutics, Inc. and VP-Commercial Strategy & New Product Planning at Ironwood Pharmaceuticals, Inc.

Ms. Gault previously held the position of Head-Sales & Marketing at Genzyme Corp.

She received an undergraduate degree from Boston College.

Transactions

Date Shares Transaction Value

Officers and Executives

Dr. Peter M. Hecht
Chief Executive Officer & Director
Ms. Cheryl Gault
Chief Operating Officer
Ms. Anjeza Gjino
Secretary & Chief Financial Officer
Dr. G. Todd Milne
Senior Vice President-External Innovation
Dr. Jennifer Chickering
Vice President-Clinical Strategy
Dr. Errol B. de Souza
Chairman
Dr. Steven E. Hyman
Independent Director
Ms. Stephanie Lovell
Independent Director
Dr. Michael E. Mendelsohn
Independent Director
Dr. Ole Isacson
Independent Director
Mr. Terrance G. McGuire
Independent Director
Mr. George H. Conrades
Independent Director
Link to MarketWatch's Slice.